
All News
All series
All All News
Advertisement


Tafinlar and Mekinist target a specific tumor mutation in patients with metastatic or unresectable melanoma, a type of skin cancer.









Research and awareness help patients to understanding and manage chemotherapy-related peripheral neuropathy.


















Finalist essay for CURE's 2013 Extraordinary Healer Award for Oncology Nursing.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5








